End of the Road for Immune Checkpoint Inhibitors in Prostate Cancer?

End of the Road for Immune Checkpoint Inhibitors in Prostate Cancer?

(MedPage Today) -- Adding an immune checkpoint inhibitor (ICI) to chemotherapy for advanced prostate cancer failed to improve survival as compared with chemotherapy alone, according to final results from a large randomized trial. Men with metastatic...

From the Prostate Cancer Research Desk: Immunotherapy Combination Shows Promise in Prostate Cancer

Combining immune checkpoint inhibitors with a targeted tumor-suppressing treatment might help patients’ own immune systems fight prostate cancer, according to new findings published in the journal Cancer Immunology Research. To multiply and spread, cancer cells must be able to escape the immune system. One way they do this is by making checkpoint proteins, which keep immune cells (called T cells) from killing cancer cells in the body. Immune che…